RaySearch Laboratories AB (publ)

Stockholm Stock Exchange RAY-B.ST

RaySearch Laboratories AB (publ) Return on Equity (ROE) for the year ending December 31, 2023: 11.09%

RaySearch Laboratories AB (publ) Return on Equity (ROE) is 11.09% for the year ending December 31, 2023, a 206.63% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

RaySearch Laboratories AB (publ) Return on Equity (ROE) for the year ending December 31, 2022 was 3.62%, a 149.65% change year over year.
RaySearch Laboratories AB (publ) Return on Equity (ROE) for the year ending December 31, 2021 was -7.29%, a -457.26% change year over year.
RaySearch Laboratories AB (publ) Return on Equity (ROE) for the year ending December 31, 2020 was -1.31%, a -118.30% change year over year.
RaySearch Laboratories AB (publ) Return on Equity (ROE) for the year ending December 31, 2019 was 7.15%, a -40.17% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Stockholm Stock Exchange: RAY-B.ST

RaySearch Laboratories AB (publ)

CEO	Dr. Johan Lof Ph.D.
IPO Date	Jan. 3, 2000
Location	Sweden
Headquarters	Sveavägen 44
Employees	411
Sector	Technology
Industries 3D Printing Augmented Reality (AR) Biotechnology Graphics Processing Unit (GPU) Medical Instruments Robotics Software-as-a-Service (SaaS) Telehealth

Description

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Key trends

Past 5 years